Cardamom Seeds (Elettaria cardamomum)

Cardamom seeds (Elettaria cardamomum) contain bioactive volatile oils — primarily 1,8-cineole and α-terpinyl acetate — along with polyphenols that modulate insulin signaling, inflammatory cytokines, and vascular tone. These compounds interact with PPAR-γ receptors and antioxidant pathways to produce documented metabolic and cardiovascular effects.

Origin & History

Cardamom seeds come from Elettaria cardamomum (L.) Maton, a perennial plant in the Zingiberaceae family native to India's Malabar Coast, Guatemala, and Southeast Asia. The seeds are harvested from dried pods and typically processed through hot-water extraction, supercritical CO2 extraction, or direct powdering.

Historical & Cultural Context

Cardamom has been used for over 1,000 years in Ayurvedic and Unani medicine systems for digestive issues, respiratory ailments, and as a carminative spice. Traditional Persian and Islamic medicine employed it for metabolic disorders, with historical use including anti-inflammatory and antihypertensive applications in herbal formulations.

Health Benefits

• May improve glycemic control in type 2 diabetes - one RCT showed significant reductions in HbA1c, insulin, and HOMA-IR with 3g/day for 10 weeks (moderate evidence)
• Potentially reduces blood pressure - one RCT found significant decreases in systolic and diastolic BP in stage 1 hypertension patients with 3g/day for 12 weeks (preliminary evidence)
• May improve lipid profiles - one RCT showed reduced total cholesterol (p=0.02) and LDL-C (p=0.01) with supplementation (preliminary evidence)
• Possibly reduces inflammation - systematic review found significant hs-CRP reduction in studies ≥10 weeks duration (preliminary evidence)
• May enhance antiviral immunity through type I interferon responses via STING-dependent pathways (in-vitro evidence only)

How It Works

The volatile oil constituent 1,8-cineole and flavonoids in cardamom activate PPAR-γ receptors, enhancing insulin sensitivity and reducing HOMA-IR. Cardamom polyphenols inhibit NF-κB signaling, suppressing pro-inflammatory cytokines such as TNF-α and IL-6, while also inhibiting ACE (angiotensin-converting enzyme) activity, contributing to vasodilation and blood pressure reduction. Additionally, α-terpinyl acetate and other terpenoids exhibit antioxidant activity by scavenging reactive oxygen species and upregulating Nrf2-mediated antioxidant enzymes.

Scientific Research

Clinical evidence for cardamom is limited to small RCTs primarily in metabolic conditions, with mixed results. A systematic review (PMID: 36181264) of green cardamom in metabolic syndrome found potential benefits on blood pressure and inflammation, though results were inconsistent. No large-scale RCTs or meta-analyses have been conducted, and most studies used 3g/day of whole cardamom powder for 8-16 weeks.

Clinical Summary

A 10-week RCT in type 2 diabetes patients found that 3g/day of cardamom powder significantly reduced HbA1c, fasting insulin, and HOMA-IR compared to placebo, representing moderate-quality evidence. A separate RCT in stage 1 hypertension patients demonstrated significant reductions in both systolic and diastolic blood pressure following cardamom supplementation. Sample sizes in available trials are generally small (20–80 participants), and most studies are short-term, limiting the generalizability of findings. Overall, evidence is promising but preliminary; large-scale, long-duration RCTs are needed before firm clinical recommendations can be made.

Nutritional Profile

Per 100g dried cardamom seeds: Calories ~311 kcal, Carbohydrates ~68g (of which dietary fiber ~28g, representing ~100% DV), Protein ~11g, Total Fat ~7g (predominantly unsaturated: oleic acid ~37% of fatty acids, linoleic acid ~32%, palmitic acid ~18%). Key micronutrients: Manganese ~28mg (1,217% DV - exceptionally high, primary mineral of note), Iron ~14mg (~78% DV), Zinc ~7.5mg (~68% DV), Magnesium ~229mg (~54% DV), Calcium ~383mg (~29% DV), Potassium ~1,119mg (~24% DV), Phosphorus ~178mg (~14% DV). Vitamins: Vitamin C ~21mg (~23% DV), Niacin (B3) ~1.1mg, Riboflavin (B2) ~0.18mg, Thiamine (B1) ~0.20mg. Primary bioactive compounds: Volatile essential oil constituents comprising 2–10% of seed weight, dominated by 1,8-cineole (eucalyptol, ~36–60% of essential oil), α-terpinyl acetate (~25–35%), linalool (~3–6%), α-terpineol (~3%), sabinene (~3%), and limonene (~2–3%). Non-volatile bioactives include flavonoids (quercetin, kaempferol glycosides), terpenoids, and phenolic acids including caffeic and protocatechuic acid at low concentrations (~50–200 mg/100g total phenolics). Fixed oil fraction contains phospholipids and plant sterols (β-sitosterol predominant). Bioavailability notes: Essential oil compounds are lipophilic and absorption is enhanced with dietary fat co-ingestion; grinding seeds significantly increases volatile oil bioavailability compared to whole seeds; the high fiber content may moderately reduce mineral absorption via phytate binding, though manganese and iron bioavailability from cardamom are considered moderate; 1,8-cineole is rapidly absorbed across gastrointestinal membranes and detectable in plasma within 15–30 minutes of ingestion.

Preparation & Dosage

Clinically studied dose: 3 grams per day of green cardamom powder for 8-16 weeks. Supercritical CO2 extract studied only in animals at 550 mg/kg. No standardized extracts have been tested in humans. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cinnamon, Turmeric, Ginger, Fenugreek, Black Pepper

Safety & Interactions

Cardamom is generally recognized as safe (GRAS) at culinary doses, and supplemental doses up to 3g/day have been well tolerated in clinical trials with no serious adverse events reported. Because cardamom may lower blood glucose and blood pressure, concurrent use with antidiabetic drugs (e.g., metformin, insulin) or antihypertensives (e.g., ACE inhibitors, calcium channel blockers) could produce additive effects requiring dose monitoring. Cardamom may inhibit CYP3A4 and CYP2C9 enzymes at high doses, potentially elevating plasma levels of drugs metabolized by these pathways, though robust human data are lacking. Pregnant and breastfeeding women should limit intake to culinary amounts, as high-dose supplementation safety has not been established in these populations.